Mathilde Thrysøe

Mathilde Thrysøe

Auto-generated profile, based on publicly available information

Mathilde Thrysøe

Department of Neurology, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2023 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
VRVinni Faber Rasmussen
Vinni Faber Rasmussen
MTMathilde Thrysøe
Mathilde Thrysøe
JNJens Randel Nyengaard
Jens Randel Nyengaard
HTHatice Tankisi
Hatice Tankisi
PKPáll Karlsson
Páll Karlsson
ATAstrid Juhl Terkelsen
Astrid Juhl Terkelsen
To estimate the prevalence of large fiber (LFN), small fiber (SFN), and autonomic neuropathy in adolescents with type 1 diabetes using confirmatory tests known from adults and to identify risk factors and bedside methods for neuropathy. Sixty adolescents with type 1 diabetes (diabetes duration > five years) and 23 control subjects underwent neurological examination and confirmatory diagnostic tests for neuropathy, including nerve conduction studies, skin biopsies determining intraepidermal nerve fiber density, quantitative sudomotor axon reflex test (QSART), cardiovascular reflex tests (CARTs), and tilt table test. Possible risk factors were analyzed. Bedside tests (biothesiometry, DPNCheck®, Sudoscan, and Vagus®device) were compared with the confirmatory tests using ROC analysis. The prevalence of neuropathies in the adolescents with diabetes (mean HbA1c 7.6% (60 mmol/mol)) was as follows: 14% confirmed/26% subclinical LFN, 2% confirmed/25% subclinical SFN, 20% abnormal QSART, 8% abnormal CARTs, and 14% orthostatic hypotension. Higher age, higher insulin dose, previous smoking, and higher triglycerides level were found to increase the relative risk for neuropathy. The bedside tests showed poor to acceptable concordance with the confirmatory tests (all, AUC ≤ 0.75). The diagnostic tests confirmed the presence of neuropathy in adolescents with diabetes and underscore the importance of prevention and screening.

28 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VRVinni Faber Rasmussen
Vinni Faber Rasmussen
MTMathilde Thrysøe
Mathilde Thrysøe
PKPáll Karlsson
Páll Karlsson
EVEsben Thyssen Vestergaard
Esben Thyssen Vestergaard
KKKurt Kristensen
Kurt Kristensen
KKKlaus Krogh
Klaus Krogh
Background: To assess the prevalence of objective signs of gastrointestinal (GI) autonomic neuropathy (AN) in adolescents with type 1 diabetes (T1D). In addition, to investigate associations between objective GI findings and self-reported symptoms or other findings of AN. Methods: Fifty adolescents with T1D and 20 healthy adolescents were examined with a wireless motility capsule to assess the total and regional GI transit times and motility index. GI symptoms were evaluated with the GI Symptom Rating Scale questionnaire. AN was evaluated with cardiovascular and quantitative sudomotor axon reflex tests. Results: There was no difference in GI transit times in adolescents with T1D and healthy controls. Adolescents with T1D had a higher colonic motility index and peak pressure than the controls, and GI symptoms were associated with low gastric and colonic motility index (all p < 0.05). Abnormal gastric motility was associated with the duration of T1D, while a low colonic motility index was inversely associated with “time in target range” for blood glucose (all p < 0.01). No associations were found between signs of GI neuropathy and other measures of AN. Conclusions: Objective signs of GI neuropathy are common in adolescents with T1D and it seems to require early interventions in patients at high risk of developing GI neuropathy.

10 February 2022 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
VRVinni Faber Rasmussen
Vinni Faber Rasmussen
MTMathilde Thrysøe
Mathilde Thrysøe
HTHatice Tankisi
Hatice Tankisi
PKPáll Karlsson
Páll Karlsson
EVEsben Thyssen Vestergaard
Esben Thyssen Vestergaard
ATAstrid Juhl Terkelsen
Astrid Juhl Terkelsen
Treatment‐induced neuropathy of diabetes (TIND) is a condition occurring within weeks after a rapid decline in blood glucose. This case report illustrates consequences in an adolescent with TIND. Gold standard methods diagnosing large fiber, small fiber, and autonomic neuropathy were abnormal at 1.5 years of follow‐up. Awareness of TIND is important.

3 March 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MTMathilde Thrysøe
Mathilde Thrysøe
TPTina Parkner
Tina Parkner
HTHatice Tankisi
Hatice Tankisi
JNJens Randel Nyengaard
Jens Randel Nyengaard
EVEsben Thyssen Vestergaard
Esben Thyssen Vestergaard
VRVinni Faber Rasmussen
Vinni Faber Rasmussen
Introduction: The aim of this study was to investigate serum Neurofilament Light polypeptide (NfL) as a biomarker for diabetic polyneuropathy (DPN) in adolescents with type 1 diabetes (T1D). Secondarily, to investigate vitamin B 12 (B 12 ) deficiency as a cause for DPN in adolescents with T1D. Research design and methods: Cross-sectional study. Sixty Danish adolescents with T1D (age 15–18 years, diabetes duration >5 years) and 23 age-matched control subjects were included. Based on nerve conduction studies (NCS), intraepidermal nerve fibre density (IENFD) and neurological examination, patients were divided into three groups: (1) T1D without DPN, (2) T1D with subclinical DPN and (3) T1D with confirmed DPN. Blood levels of NfL, B 12 , B 12 -binding protein holotranscobalamin (HoloTC) and methylmalonic acid (MMA) were determined. Results: Twenty-four of the adolescents were without DPN, twenty-one had subclinical DPN and eight had confirmed DPN. NCS was not conducted in three participants and four patients did not have blood samples taken. There were no significant differences in NfL levels or any of the B 12 parameters between any of the groups. Conclusions: NfL used in a cross-sectional manner was not found useful to distinguish between the adolescents with DPN and those without. Vitamin B 12 deficiency did not contribute to neuropathy in Danish adolescents with T1D.

1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
VRVinni Faber Rasmussen
Vinni Faber Rasmussen
MTMathilde Thrysøe
Mathilde Thrysøe
PKPáll Karlsson
Páll Karlsson
JNJens Randel Nyengaard
Jens Randel Nyengaard
KKKurt Kristensen
Kurt Kristensen
EVEsben Thyssen Vestergaard
Esben Thyssen Vestergaard
Aim: This study is aimed at assesing the impact of neuropathy on well‐being and health‐related quality of life (HRQoL) in adolescents with Type 1 diabetes (T1D). Methods: In a cross‐sectional study, 60 adolescents with T1D (15–18 years, diabetes duration > 5 years) were enrolled. Clinical and biochemical data were collected, and well‐being and HRQoL were assessed using the WHO‐5 well‐being index and DISABKIDS questionnaires, including diabetes‐specific modules. Diagnostic tests for large fiber neuropathy (LFN), small fiber neuropathy (SFN), and autonomic neuropathy were performed as part of the T1DANES study. The participants were divided into groups depending on the presence or absence of specific forms of neuropathy. Those with autonomic neuropathy were further divided depending on reported autonomic symptoms (Composite Autonomic Symptom Scale 31 (COMPASS‐31) score ≥ 24 or < 24). Additionally, the data was compared to 23 healthy control subjects. Results: The median diabetes duration was 8.5 years (range 5–17), and the HbA1c was 60 mmol/mol (7.6%) (range 41–93 [5.9%–10.6%]). Adolescents who had abnormal autonomic function test(s) and a COMPASS‐31 score ≥ 24 exhibited lower WHO‐5 well‐being index compared to the following groups: those with abnormal autonomic test(s) and fewer autonomic symptoms (COMPASS‐31 < 24), the remaining adolescents with T1D, and the control subjects ( p values < 0.05). There was no significant difference in the total score of DISABKIDS between the groups; however, the subdomain social inclusion was lowest in the group with COMPASS‐31 ≥ 24. Gastric motility index ( p = 0.04) and uroflow acceleration ( p = 0.02) were positively associated with the total score of DISABKIDS. Females reported lower well‐being and HRQoL than males ( p values < 0.05); in total, 28% had a WHO‐5 well‐being index < 50. Conclusion: In conclusion, adolescents with diabetic autonomic neuropathy who also reported autonomic symptoms had lower well‐being and impaired social inclusion. Adolescents with symptoms of neuropathy and females appear to be at higher risk of lower well‐being, and using standardized screening tools helps to identify the subjects at risk.